The Global Metagenomics Market: Fueled by
Technological Advancement

The metagenomics market involves sequencing of genomes
obtained directly from environmental samples containing unknown microbial
organisms. Metagenomic techniques are used to identify microorganisms present
in clinical or environmental samples without isolating or culturing them. This
helps in discovering novel genetic elements and microbes from various
ecosystems. The technique also allows large-scale analyses of complete genetic
content present in microbial communities.

The
metagenomics market is estimated to be valued at USD 2.18 Bn in 2024 and is
expected to reach USD 3.77 Bn by 2031, exhibiting a compound annual growth rate
(CAGR) of 8.1% from 2024 to 2031.



Key Takeaways



Key players operating in the metagenomics market: Key players operating in the
metagenomics market are Bio-Rad Laboratories, Inc., Illumina, Inc.,
PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Novogene Co., Ltd., Promega
Corporation, QIAGEN, Takara Bio, Inc., Oxford Nanopore Technologies, F.
Hoffmann-La Roche Ltd, and PacBio.



Growing the market: The Metagenomics
Market Size is witnessing high owing to the growing demand for
identification of unknown pathogens, development of biofuels, and biomarker
discovery. Metagenomics helps in understanding microbial diversity and provides
comprehensive details on microbial communities.



Global expansion of the market: Key players in the metagenomics market are
expanding their presence globally by partnering with research institutes and
laboratories. The market is expected to grow at a high rate in emerging economies
such as Asia Pacific and Latin America due to increasing R&D expenditures
on metagenomics.

Get
More Insights on- Metagenomics
Market